Dr. Mammen is a U.S.-trained Internist, specialized in infectious diseases, former biotech executive and retired U.S. Army colonel with 25 years of product development experience. He led vaccine trials involving 9,000+ participants globally (clinical study Phases I-III). His expertise in multidisciplinary team leadership, clinical strategy, pandemic preparedness, study design, clinical document preparation, CRO oversight and high-level medical monitoring will be key to the successful clinical development of VT-105.